OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, March 11th BMGP, NXPC, UOMO, CYTO, USNT

OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets.  In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.

Our Stocks to Watch today include Biomagnetics Diagnostics Corporation (OTC:BMGP), NeXplore Corporation (OTC: NXPC), UOMO Media Inc. (OTCBB: UOMO), Cytogen Corporation (NASD: CYTO), US National Telecom (OTC: USNT)

For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php

For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/

BIOMAGNETICS DIAGNOSTICS CORPORATION (OTC: BMGP)

Detailed Quote: http://www.otcpicks.com/quotes/BMGP.php 

Company Profile: http://www.otcpicks.com/biomagnetics/biomagnetics.htm

Biomagnetics Diagnostics Corporation, through its wholly owned subsidiary Biospectrum Technologies, Inc., a company that has designed and patented revolutionary diagnostic equipment and immunoassays, will identify market inadequacies and fill those needs with new technologies and highly specific and sensitive assays that are qualitative (yes/no) and quantitative (viral load/degree of infection), easily performed and cost effective. For more information, visit www.biomagneticsbmgp.com.

NEXPLORE CORPORATION (OTC: NXPC)

Detailed Quote: http://www.otcpicks.com/quotes/NXPC.php

Company Profile: http://www.otcpicks.com/nexplore/nexplore.htm

NeXplore Technologies is developing a Web 2.0 search engine and an assortment of social networking portals and tools that will enable users to personalize their Web experience and tailor it to their unique needs, interests, and online pursuits. The Company’s social computing platform, MyCircle.com, offers an enhanced, user-friendly graphical interface search engine, combined with innovative backend technology, which enables users to improve the way they connect with information and other people on the Worldwide Web. MyCircle’s Web 2.0 interface provides users with an online tool for sharing their Blogs, Voice-Over IP, photos and documents, podcasts and videocasts, classified advertising, instant messages, SMS text messages, Chat and personal profiles.

UOMO MEDIA INCORPORATED (OTCBB: UOMO)

Detailed Quote: http://www.otcpicks.com/quotes/UOMO.php 

Company Profile: http://www.otcpicks.com/uomo-media/uomo-media.htm 

UOMO Media Inc. is a publicly trading entertainment company that acquires, produces, manages, and monetizes entertainment-based intellectual property globally. The company is focusing on the development of four core business units: UOMO Digital, UOMO Recorded Music, UOMO Talent Management and UOMO Publishing. There is a massive and ongoing demand for music and entertainment. IFPI estimates that globally, the broader music industry was worth US$130 billion in 2006.

CYTOGEN CORPORATION (NASD: CYTO)

"Up 25.02% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CYTO.php

Cytogen Corporation, a biopharmaceutical company, builds, develops, and commercializes a portfolio of specialty pharmaceutical products for the treatment and care of cancer patients. It markets QUADRAMET (samarium Sm-153 lexidronam injection), PROSTASCINT (capromab pendetide), and SOLTAMOX (tamoxifen citrate) to the United States oncology market. QUADRAMET is approved for the treatment of pain in patients whose cancer has spread to the bone, PROSTASCINT is a prostate-specific membrane antigen (PSMA)-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer, and SOLTAMOX is the liquid hormonal therapy approved in the U.S. for the treatment of breast cancer in adjuvant and metastatic settings. The company intends to introduce its fourth approved oncology product, CAPHOSOL, an advanced electrolyte solution for the treatment of oral mucositis and dry mouth. CAPHOSOL is approved in the U.S. as a prescription medical device. It is also developing CYT-500, a third-generation radiolabeled antibody to treat prostate cancer. The company was founded in 1980. It was formerly known as Hybridex, Inc. and subsequently changed its name to Cytogen Corporation. Cytogen Corporation is headquartered in Princeton, New Jersey.

U.S. NATIONAL TELECOM (OTC: USNT)

"Up 33.33% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/USNT.php

US National Telecom (USNT) (http://www.usnationaltelecom.com/) is a publicly traded technology company, headquartered in Denver, Colorado. The Company focus is on building a large VoIP and Internet services company by expanding to process international voice traffic and acquiring companies in the VoIP services and technology marketplace.

About OTCPicks.com

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor.  The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has been compensated seven thousand five hundred dollars by a third party for BMGP advertising and promotional services. OTCPicks.com has been compensated fifty thousand restricted shares by the company for NXPC advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by a third party (Haynes Capital) for UOMO advertising and promotional services.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.